Literature DB >> 26997107

Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma.

Mikiko Ise1, Keiko Matsubayashi2, Hideki Tsujimura3, Kyoya Kumagai3.   

Abstract

Entities:  

Keywords:  CD138; CDC; Cytogenetic abnormality; Daratumumab; Monoclonal antibody

Mesh：

Substances：

Year:  2016        PMID： 26997107     DOI： 10.1016/j.clml.2016.02.037

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  5 in total

1.  CD38-Negative Myeloma with Anaplastic Morphology at Presentation: A Case Report.

Authors:  Neha Singh; Narendra Agrawal; Anurag Mehta; Ajit Panaych; Radhika Sekhri
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-10       Impact factor: 0.900

Review 2.  Immunotherapies targeting CD38 in Multiple Myeloma.

Authors:  Djordje Atanackovic; Mary Steinbach; Sabarinath Venniyil Radhakrishnan; Tim Luetkens
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

3.  CD38 - Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report.

Authors:  An Thi Vinh Do; Le Lan Anh
Journal:  Cureus       Date:  2022-01-03

Review 4.  Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma.

Authors:  Muthulekha Swamydas; Elena V Murphy; James J Ignatz-Hoover; Ehsan Malek; James J Driscoll
Journal:  J Hematol Oncol       Date:  2022-02-16       Impact factor: 17.388

5.  Microfluidic enrichment of plasma cells improves treatment of multiple myeloma.

Authors:  Yunjing Zeng; Li Gao; Xiaoqing Luo; Yan Chen; Mustafa H Kabeer; Xuelian Chen; Andres Stucky; William G Loudon; Shengwen C Li; Xi Zhang; Jiang F Zhong
Journal:  Mol Oncol       Date:  2018-05-12       Impact factor: 6.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.